Treatment of rats with an anti-(+)-methamphetamine monoclonal antibody shortens the duration of action of repeated (+)-methamphetamine challenges over a one month period

This study assessed clinical scenarios of continuing monoclonal antibody (mAb) treatment for (+)-methamphetamine (METH) addiction, and the implications of missing or discontinuing this therapy. We hypothesized that chronic anti-METH mAb7F9 (METH K(D) = 9 nM) treatment of rats could significantly dec...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Vaccine
Huvudupphovsmän: Hambuchen, Michael D., Rüedi-Bettschen, Daniela, Williams, D. Keith, Hendrickson, Howard, Owens, S. Michael
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2014
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4250301/
https://ncbi.nlm.nih.gov/pubmed/25252196
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2014.09.025
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk